-
'Role model' Stokes set to open for Adelaide Strikers
-
Farming experts tout 'conscious' food systems to fix agriculture woes
-
Palau urges 'unified' Pacific response to China missile test
-
George Lucas unveils art galaxy at his new LA museum
-
Grinding away: in remote Appalachia, old mills fuel US clean food dreams
-
Veteran Wallaby Slipper targets fifth World Cup after Brumbies deal
-
Sabalenka races into US Open third round
-
Sabalenka storms into US Open third round as Pegula, Medvedev advance
-
Chinese lucky loser stuns Jodar at US Open
-
Zverev looks to improve after first-round scare
-
US Open under the influence: content creators spark debate
-
Raiders to start Cousins over top NFL Draft pick Mendoza
-
NBA hammers Clippers over Leonard salary cap violations
-
Palantir chief says France's digital sovereignty push 'backfiring'
-
NBA strips five first-round draft picks from Clippers for Leonard salary cap violations
-
US energy firms dominate Venezuela deals worth billions
-
Kane brace helps Bayern win German Cup opener
-
Iran, US trade threats after escalation in fighting
-
Migrant plight, local anger divide Ceuta one month after influx
-
US jury deadlocks again in Lindsay Clancy's child murder trial
-
Outrage as Maltese tycoon acquitted of reporter's murder
-
Lake America? No way, Canadians say
-
Rare train of Pacific cyclones fueled by historic El Nino
-
Spain report flags Moroccan police failings in Ceuta migrant rush
-
Macron, King Charles hail UK-France ties after viewing Bayeux Tapestry
-
Tech bosses press G20 to build data centers, but split on risk
-
Fury hits out at 'coward' Joshua as 'Battle of Britain' talks go on
-
Dolly Parton to get new Hollywood star after vandalism
-
Maltese tycoon acquitted of masterminding reporter's murder
-
Trump 'happy' Prince Harry and Meghan have left US
-
George Clooney: a Hollywood icon and campaigner
-
Michelson shocks Nakashima in US Open clash of rising Americans
-
Europe, US closer than they look on tech rules, says EU tech chief
-
Another body recovered after ferry capsizes off northern Cyprus: official
-
Clooney honoured as Hollywood-light Venice Film Festival kicks off
-
Cupertino Chamber President Claudio Bono Invited to White House with GiveaRoof 3-Year Plan to End Homelessness
-
Third-ranked Pegula, Medvedev power into US Open third round
-
Trump floats renaming Strait of Hormuz as 'Trump Strait'
-
Davis-Woodhall a doubt for Ultimate Championship after car crash
-
Man City, Chelsea fuel record-breaking Premier League transfer window
-
Third-ranked Pegula powers into US Open third round
-
Balogun rejected Everton move over transfer 'treatment'
-
Uber says laying off 'about 10%' of workforce worldwide
-
Northampton seek 'happy medium' in bid to keep England star Pollock
-
US judge rejects bid to break up Google's ad business
-
US energy secretary in Venezuela to sign Trump's 'biggest' oil deal
-
Rupert Murdoch 'very happy' to be played by Guy Pearce in new film
-
Branagh takes on action role in Apple's Cold War comedy 'Mayday'
-
Wall Street stocks rise despite bond yields, oil rising
-
Lawson fills in again for injured Hadjar at Monza
Datametrex Integrates AI to Healthcare To Enhance Efficiencies
TORONTO, ONTARIO / ACCESS Newswire / March 10, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE: D4G)(OTC:DTMXF) is pleased to announce the integration of AI software within its EMR (Electronic Medical Records) system to support physicians at the point of care.
These AI-assisted functionalities include automated clinical documentation, intelligent document classification, real-time charting support, and AI-generated patient care planning. The system converts physician-patient conversations into structured notes, organizes incoming medical documents such as faxes and eDeliveries, and suggests chart entries based on visit details. It can also generate personalized care plans after appointments to support follow-up care and treatment adherence. All final clinical and prescribing decisions remain under the control of licensed healthcare providers.
Key Highlights of the Integrated AI Healthcare Solution:
AI-assisted documentation that converts patient conversations into structured visit notes within the EMR
Automated classification of incoming medical documents with AI-suggested labeling
Real-time charting support with suggested structured entries based on visit details
AI-generated post-visit care plans to support follow-up care and chronic condition management
Secure, regulatory-compliant handling of patient data to enhance workflow efficiency
Designed to support physician decision-making, not replace professional judgment
Healthcare systems worldwide are facing increasing administrative demands, rising patient volumes, and clinician burnout. By integrating these AI-driven capabilities, Datametrex aims to reduce the time physicians spend on manual documentation, enabling more focus on direct patient care while improving operational efficiency.
"Integrating AI-assisted functionality into the EMR system reflects Datametrex's commitment to leveraging practical, high-impact AI solutions", said Paul Haber, CEO of Datametrex. "These capabilities provide physicians with intelligent recommendations at the point of care, enhancing efficiency and accuracy while keeping professional oversight central".
This initiative aligns with Datametrex's broader strategy of incorporating AI across high-growth sectors where intelligent automation can deliver measurable operational improvements.
About Datametrex
Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and Healthcare. The Company specializes in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.
For more on Datametrex, please visit our Company website (www.datametrex.com).
For Additional Information
Paul Haber, C.P.A., C.A., C.Dir
CEO & Chairman
[email protected]
(416) 318-6501
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.
Forward-Looking Statements
This news release contains "forward-looking statements," which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," and similar expressions. Such statements include expectations related to healthcare business and other Company plans.
While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company's ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.
Factors that could cause actual results to differ materially are detailed under "Risk Factors" in Datametrex's management's discussion and analysis and available on the Company's profile at www.sedarplus.ca.
This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.
###
SOURCE: DataMetrex AI Ltd.
View the original press release on ACCESS Newswire
P.Silva--AMWN